Government Drug Price Negotiations Offer A False Promise
Forbes | Sally Pipes
July 5, 2022
With inflation rising and midterm elections just months away, Democrats are desperate for something they can pitch to voters as a reason to keep them in control of Congress.
They’re hoping a watered-down version of their Build Back Better Act could do the trick. Sen. Joe Manchin, D-W. Va., who helped shoot the bill down last winter, has met repeatedly with Senate Majority Leader Charles Schumer, D-N.Y., in recent weeks in an effort to hash out a compromise on the massive spending package.
Read more. . .
|
|
The FDA Is Blocking Game Changing New Drugs For Kidney Disease
Issues & Insights | Henry Miller
July 1, 2022
Imagine you’ve been diagnosed with chronic kidney disease, told by your physician that if it can’t be managed, you may eventually need a transplant or long-term dialysis. This scary situation is one faced by hundreds of thousands of Americans every year.
Read more. . .
|
|
Health Care Is Not a Right, No Matter What the Left Says
Townhall | Sally Pipes
June 30, 2022
At the recent unveiling of his latest plan for Medicare for All, Sen. Bernie Sanders, I-Vt., evoked a familiar theme. “Health care,” he said, “is a human right that all Americans, regardless of income, are entitled to.”
But health care is neither a right nor a privilege. It’s an aggregate of goods and services. The task of health policy is to ensure timely, affordable access to these goods and services for all who need them — and to do so without sacrificing the quality of care.
Read more. . .
|
|
|
|